Inhibition of the PLK1‐Coupled Cell Cycle Machinery Overcomes Resistance to Oxaliplatin in Colorectal Cancer-Reference-Cited by-同舟云学术

Inhibition of the PLK1‐Coupled Cell Cycle Machinery Overcomes Resistance to Oxaliplatin in Colorectal Cancer

Published:2021-10-28 Issue:23 Volume:8 Page:2100759
ISSN:2198-3844
Container-title:Advanced Science
language:en
Short-container-title:Adv. Sci.

Author:

Yu Zhaoliang¹,Deng Peng²,Chen Yufeng¹,Liu Shini²,Chen Jinghong²,Yang Zihuan³,Chen Jianfeng²,Fan Xinjuan⁴,Wang Peili²,Cai Zerong¹,Wang Yali²,Hu Peishan³,Lin Dezheng⁵,Xiao Rong⁶,Zou Yifeng¹,Huang Yan⁴,Yu Qiang⁷⁸,Lan Ping¹³,Tan Jing²⁹^ORCID,Wu Xiaojian¹³

Affiliation:

1. Department of Colorectal Surgery The Sixth Affiliated Hospital Sun Yat‐sen University Guangzhou Guangdong 510655 P. R. China

2. Sun Yat‐sen University Cancer Center State Key Laboratory of Oncology in South China Collaborative Innovation Center of Cancer Medicine Guangzhou Guangdong 510060 P. R. China

3. Guangdong Provincial Key Laboratory of Colorectal and Pelvic Floor Diseases Guangdong Institute of Gastroenterology The Sixth Affiliated Hospital Sun Yat‐sen University Guangzhou Guangdong 510655 P. R. China

4. Department of Pathology The Sixth Affiliated Hospital Sun Yat‐sen University Guangzhou Guangdong 510060 P. R. China

5. Department of Endoscopic Surgery The Sixth Affiliated Hospital Sun Yat‐sen University Guangzhou Guangdong 510060 P. R. China

6. Department of Biomedical Sciences City University of Hong Kong Hong Kong SAR 999077 China

7. Cancer and Stem Cell Biology Program Duke‐NUS Medical School Singapore 169857 Singapore

8. Genome Institute of Singapore A*STAR Singapore 138672 Singapore

9. Affiliated Cancer Hospital and Institute of Guangzhou Medical University Guangzhou Guangdong 510095 P. R. China

Funder

National Natural Science Foundation of China

Fundamental Research Funds for the Central Universities

Natural Science Foundation of Guangdong Province

Medical Science and Technology Foundation of Guangdong Province

Publisher

Wiley

Subject

General Physics and Astronomy,General Engineering,Biochemistry, Genetics and Molecular Biology (miscellaneous),General Materials Science,General Chemical Engineering,Medicine (miscellaneous)

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/advs.202100759

Reference57 articles.

1. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

2. The Chromosomal Instability Pathway in Colon Cancer

3. Chromosomal Instability Confers Intrinsic Multidrug Resistance

4. Plk1 Inhibitors in Cancer Therapy: From Laboratory to Clinics

5. Cyclin-dependent kinase 4 and 6 inhibitors for hormone receptor-positive breast cancer: past, present, and future

Cited by 44 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. OTU deubiquitinase, ubiquitin aldehyde binding 2 (OTUB2) modulates the stemness feature, chemoresistance, and epithelial-mesenchymal transition of colon cancer via regulating GINS complex subunit 1 (GINS1) expression;Cell Communication and Signaling;2024-08-29

2. Molecular Feature-Based Classification of Retroperitoneal Liposarcoma: A Prospective Cohort Study;2024-08-09

3. Exploring Predictive and Prognostic Biomarkers in Colorectal Cancer: A Comprehensive Review;Cancers;2024-08-08

4. CDK4/6 inhibition augments anti-tumor efficacy of XPO1 inhibitor selinexor in natural killer/T-cell lymphoma;Cancer Letters;2024-08

5. Sanggenol L induces ferroptosis in non-small cell lung cancer cells via regulating the miR-26a-1-3p/MDM2/p53 signaling pathway;Biochemical Pharmacology;2024-08